NAIMS Workshop 2020

Evidence for Translation of MRI to the Clinic: The next generation of MRI use in the MS Clinic

West Palm Beach, FL | February 26, 2020

Introduction

8:30 - 8:40 Welcome and Introduction
Roland Henry, University of California, San Francisco

Session 1: Clinically Relevant MRI Prognostic Markers

Moderators: Corree Laule, The University of British Columbia; Susie Huang, Harvard Medical School

8:40 - 9:10 Prognostic Value of the Clinical Radiology Report
David Li, University of British Columbia
9:10 - 9:40 Defining Clinical Relevance for Translation to Practice
Nancy Sicotte, Cedars Sinai
9:40 - 10:00 Session 1 Speaker Panel Discussion

Session 2: Potentially Clinically Relevant MRI Prognostic Markers: Atrophy

Moderators: Susan Gauthier, Weill Cornell Medicine; Roland Henry, University of California, San Francisco

10:20 - 10:40 Does Brain Atrophy Predict Disease Progression
Elizabeth Fisher, Biogen
10:40 - 11:00 Does Spinal Cord Atrophy Predict Disease Progression
Jiwon Oh, University of Toronto
11:00 - 11:20 Session 2 Speaker Panel Discussion

Session 3: Potentially Clinically Relevant MRI Prognostic Markers: Lesions  

Moderators: Corree Laule, The University of British Columbia; Susie Huang, Harvard Medical School

11:20 - 11:35 The Case for QSM/SWI
Susan Gauthier, Weill Cornell Medicine
11:35 - 11:50 The Case for Leptomeningeal Enhancement
Jon Zurawski, Brigham and Women's Hospital
11:50 - 12:05 The Case for Grey Matter Lesions
Constantina Treaba, Massachusetts General Hospital
12:05 - 12:20 The Case for Disappearing White Matter Lesions
Robert Zivadinov, University at Buffalo
12:20 - 12:35 What Advanced MS Imaging Markers Should Make It to Your Workstation, and How Might That Look?
Daniel Reich, National Institutes of Health
12:35 - 12:50 Session 3 Panel Discussion

Session 4: Potential for Precision: Statistical Aspects

Moderators: Christina Azevedo, University of Southern California; Roland Henry, University of California, San Francisco

14:00 - 14:40 Clinical Precision: Experience from Brain Atropy
Nicola de Stefano, University of Siena, Italy
14:40 - 15:20 The Role of Reference Values and Knowledge Integration to Prognostic Value
Taki Shinohara, University of Pennsylvania
15:20 - 15:40 Session 4 Panel Discussion

Session 5: The Ecosystem for Translation to Clinical Practice

Moderators: William Rooney, Oregon Health Sciences University; David Li, University of British Columbia

16:00 - 16:30 The Infrastructure for Delivering Quantitative Metrics in the Clinic
Michel Bilello, University of Pennsylvania
16:30 - 17:00 Regulatory and Insurance Issues
Diane Stephenson, Critical Path Institute
17:00 - 17:20 Session 5 Panel Discussion

Open Discussion and Wrap-Up

17:20 - 17:50 What are the next steps?
Roland Henry, University of California, San Francisco; Corree Laule, The University of British Columbia; Susie Huang, Harvard Medical School

Poster Viewing

18:00 - 20:00 NAIMS Poster Session